Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

105.51
+1.181.13%
Post-market: 105.38-0.1323-0.13%19:27 EDT
Volume:7.54M
Turnover:796.26M
Market Cap:131.53B
PE:277.66
High:106.44
Open:104.90
Low:104.78
Close:104.33
Loading ...

Leerink Partners Adjusts Price Target on Gilead Sciences to $105 From $104, Keeps Outperform Rating

MT Newswires Live
·
17 Apr

Gilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
17 Apr

Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell

MT Newswires Live
·
17 Apr

BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

Reuters
·
17 Apr

Nurix Therapeutics Inc - to Receive $5 Million Milestone Payment From Gilead

THOMSON REUTERS
·
17 Apr

Gilead Sciences (GILD) Stock Moves -0.74%: What You Should Know

Zacks
·
17 Apr

Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?

Insider Monkey
·
16 Apr

Goldman Sachs Adjusts Price Target on Gilead Sciences to $97 From $96, Maintains Neutral Rating

MT Newswires Live
·
15 Apr

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
12 Apr

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs -- Heard on the Street -- WSJ

Dow Jones
·
11 Apr

Press Release: Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025

Dow Jones
·
11 Apr

BRIEF-Gilead Sciences To Release First Quarter 2025 Financial Results On Thursday, April 24, 2025

Reuters
·
11 Apr

BRIEF-Gilead Sciences Announces Q1 Estimated Acquired IPR&D

Reuters
·
11 Apr

Gilead: for Q1, Expects $253.4M in Acquired Ipr&D Expenses

THOMSON REUTERS
·
11 Apr

PatientView Ranks Gilead "Best" at ESG

ACCESS Newswire
·
10 Apr

Ideaya Biosciences Begins Phase 1/2 Expansion in Urothelial Cancer Treatment Trial in Combination With Gilead's Trodelvy

MT Newswires Live
·
10 Apr

Shares of Drugmakers Down After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Stock Track | Gilead Sciences Plummets 5.21% as Trump Threatens Pharmaceutical Import Tariffs

Stock Track
·
09 Apr

Stock Track | Gilead Sciences Plunges 5% Pre-market as Trump Threatens Pharmaceutical Tariffs

Stock Track
·
09 Apr